anastrozole and Hemorrhage studies

anastrozole and Hemorrhage

anastrozole has been researched along with Hemorrhage in 2 studies

Hemorrhage: Bleeding or escape of blood from a vessel.

Research Excerpts

Excerpt	Relevance	Reference
" Because her arthralgia showed no improvement, powdered processed aconitine root was added."	3.77	A case of aromatase inhibitor (anastrozole)-induced side-effects successfully treated with Kampo medicines. ( Chino, A; Hirasaki, Y; Namiki, T; Ogawa, K; Okamoto, H; Ueda, K, 2011)
"Both anastrozole and tamoxifen were well tolerated."	2.70	Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma. ( Bonneterre, J; Buzdar, A; Nabholtz, JM; Robertson, JF; Sahmoud, T; Steinberg, M; Thürlimann, B; von Euler, M; Webster, A, 2001)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

1 (50.00)

29.6817

2010's

1 (50.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Chino, A	1
Okamoto, H	1
Hirasaki, Y	1
Ueda, K	1
Ogawa, K	1
Namiki, T	1
Bonneterre, J	1
Buzdar, A	1
Nabholtz, JM	1
Robertson, JF	1
Thürlimann, B	1
von Euler, M	1
Sahmoud, T	1
Webster, A	1
Steinberg, M	1

Studies

Chino, A

Okamoto, H

Hirasaki, Y

Ueda, K

Ogawa, K

Namiki, T

Bonneterre, J

Buzdar, A

Nabholtz, JM

Robertson, JF

Thürlimann, B

von Euler, M

Sahmoud, T

Webster, A

Steinberg, M

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
A Randomized Trial With Factorial Design Comparing Fulvestrant ± Lapatinib ± Aromatase Inhibitor in Metastatic Breast Cancer Progressing After Aromatase Inhibitor Therapy[NCT02394496]	Phase 3	396 participants (Anticipated)	Interventional	2007-11-30	Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

A Randomized Trial With Factorial Design Comparing Fulvestrant ± Lapatinib ± Aromatase Inhibitor in Metastatic Breast Cancer Progressing After Aromatase Inhibitor Therapy[NCT02394496]

Phase 3

396 participants (Anticipated)

Interventional

2007-11-30

Recruiting

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for anastrozole and Hemorrhage

Article	Year
Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma. Cancer, 2001, Nov-01, Volume: 92, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Doub	2001

Article

Year

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma.

Cancer, 2001, Nov-01, Volume: 92, Issue:9

Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Doub

2001

Other Studies

1 other study available for anastrozole and Hemorrhage

Article	Year
A case of aromatase inhibitor (anastrozole)-induced side-effects successfully treated with Kampo medicines. Journal of alternative and complementary medicine (New York, N.Y.), 2011, Volume: 17, Issue:11 Topics: Aconitine; Aconitum; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Arthralgia;	2011

Article

Year

A case of aromatase inhibitor (anastrozole)-induced side-effects successfully treated with Kampo medicines.

Journal of alternative and complementary medicine (New York, N.Y.), 2011, Volume: 17, Issue:11

Topics: Aconitine; Aconitum; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Arthralgia;

2011